Patents by Inventor Timothy K. Gallaher

Timothy K. Gallaher has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9925246
    Abstract: The present application relates to treatment of cutaneous wounds using IL-12. The methods of the invention result in improved wound closure. The methods comprise treating cutaneous wounds using topical, subcutaneous, and/or intramuscular administration of IL-12.
    Type: Grant
    Filed: June 13, 2012
    Date of Patent: March 27, 2018
    Assignee: NEUMEDICINES, INC.
    Inventors: Lena A. Basile, Dolph Ellefson, Timothy K. Gallaher
  • Publication number: 20140205561
    Abstract: The present application relates to treatment of cutaneous wounds using IL-12. The methods of the invention result in improved wound closure. The methods comprise treating cutaneous wounds using topical, subcutaneous, and/or intramuscular administration of IL-12.
    Type: Application
    Filed: June 13, 2012
    Publication date: July 24, 2014
    Inventors: Lena A. Basile, Dolph Ellefson, Timothy K. Gallaher
  • Publication number: 20130243722
    Abstract: Aspects and embodiments of the instant disclosure provide therapeutic methods and compositions comprising interleukin 12 (IL-12) useful for treating radiation-induced damage in a subject. In particular, the instant disclosure provides methods and compositions for radiation protection and/or radiation toxicity mitigation for the treatment of acute radiation syndrome and radiation induced toxicity associated with the treatment of cutaneous T-cell lymphoma.
    Type: Application
    Filed: January 18, 2013
    Publication date: September 19, 2013
    Applicant: NEUMEDICINES INC.
    Inventors: Lena Basile, Timothy K. Gallaher, Dolph D. Ellefson